APPLICATION OF GLIATILIN AND TRANSCRANIAL MICROPOLARISATION IN TREATMENT OF CHILDREN WITH AUTISTIC DISTURBANCES Russian patent published in 2011 - IPC A61K31/14 A61P25/28 A61N1/20 

FIELD: medicine.

SUBSTANCE: standard treatment regimen additionally includes gliatilin which is injected intramuscularly 2 ml daily in the therapeutic course 10 injections, and combined with transcranial micropolarisation. Transcranial micropolarisation is performed every second day at exposition 20 minutes on the first session with exposure time to be increased by 5 minutes on each following session; the therapeutic course is 5 procedures. Electrodes are applied on a frontoanterior area (an anode), on a mastoid process (cathode), on an occipital region (anode) of a hemisphere with the same name with involving thereafter an opposite hemisphere in the end of treatment.

EFFECT: improved values of a visual memory, a audio-voice memory, attention, thought processes, emotional sphere that allows reducing considerably hospitalisation length and providing higher clinical effectiveness.

10 tbl, 1 ex